(Q41014974)

25 September 2017

1 reference

title

Radioimmunotherapy of solid cancers: A review (English)

1 reference

25 September 2017

Kairemo KJ

1

1 reference

25 September 2017

publication date

1 January 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

35

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

343-355

1 reference

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Phase II radioimmunotherapy trial with 131I-CC49 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

The biologic window for chimeric L6 radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Radioimmunology. Imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Radioimmunodetection of malignant solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Intralesional radioimmunotherapy of malignant gliomas. An effective treatment in recurrent tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Polyclonal 90Yttrium labeled antiferritin for refractory Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Human anti-mouse antibody suppression with cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Effect of Lym-1 radioimmunoconjugate on refractory chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Dosimetry of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Monte Carlo estimates of absorbed dose rate in various tissues and organs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

21 January 2018

Pharmacokinetic modeling

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Radioimmunotherapy dosimetry--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Selection of radionuclides for radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Labeling of monoclonal antibodies with radionuclides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Positron emission tomography of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Microdosimetric concepts in radioimmunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

Radiation dosimetry for radioimmunotherapy. An overview of current capabilities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609101651

10.3109/02841869609101651

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference